人化脚手架设计对FGFR2向的功能活动的影响

Shyi-Chun Yii1, Tsai-Yu Lin2, Fu-Ling Chang2

  • 1Department of Biomedical Engineering, National Taiwan University, Taipei, Taiwan; Divisions of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei, Taiwan.

Journal of biotechnology
|October 19, 2025
PubMed
概括

研究人员开发了一种针对纤维细胞生长因子受体2 (FGFR2) 的人性化抗体,用于胃癌治疗. 该抗体在临床前模型中表现出显著的瘤生长抑制,没有观察到毒性,突出其治疗潜力.